Related Experiment Video
Updated: Aug 2, 2026

03:10
A Rat Model of Compound Acne
Published on: November 1, 2024
[Rosacea in the year 2001]
1Academisch Ziekenhuis, afd. Dermatologie, Postbus 5800, 6202 AZ Maastricht. mthis@sder.azm.nl
Nederlands Tijdschrift Voor Geneeskunde
|October 5, 2001
Summary
Rosacea is a chronic facial skin condition causing redness and bumps. Effective treatments include antibiotics, isotretinoin for severe cases, and vascular lasers for redness and visible blood vessels.
Area of Science:
- Dermatology
- Clinical Medicine
Context:
- Rosacea is a common chronic inflammatory skin condition affecting the face.
- Characterized by erythema, telangiectasia, papules, and pustules, it primarily impacts women aged 30-50.
- Differential diagnosis can be challenging, involving conditions like acne vulgaris and lupus erythematosus.
Purpose:
- To provide a comprehensive overview of rosacea, including its clinical presentation, pathogenesis, and differential diagnoses.
- To outline current and emerging treatment strategies for rosacea.
- To highlight the importance of accurate diagnosis and tailored treatment plans.
Summary:
- Rosacea presents with facial redness and can progress to papules and pustules.
- Pathogenesis remains unclear, but potential complications include rhinophyma and lymphoedema.
- First-line treatments involve topical or systemic antibiotics; isotretinoin is used for severe cases, and vascular lasers effectively treat erythema and telangiectasia.
Impact:
- Improved understanding of rosacea's clinical course and diagnostic challenges.
- Guidance on selecting appropriate treatments based on rosacea severity and symptoms.
- Potential for enhanced patient outcomes through timely and targeted therapeutic interventions.
More Related Videos
03:47Enhancement of Facial Rejuvenation Through a Combination of 1565 nm Non-Ablative Fractional Laser with 30% Supramolecular Salicylic Acid
Published on: September 27, 2024
07:36Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
Published on: July 3, 2025